<DOC>
	<DOCNO>NCT00984087</DOCNO>
	<brief_summary>rTMS promising , though largely untested , option treat adolescent young adult depression . This study hypothesize rTMS safely significantly alleviate depression decrease suicidal ideation adolescent young adult base previous study .</brief_summary>
	<brief_title>rTMS Adolescents Young Adults</brief_title>
	<detailed_description>After sign consent undergo thorough screening , participant administer rTMS 5 day per week 4 consecutive week ( total 20 session ) add-on current antidepressant regime . Adolescents must accompany parent legal guardian . We monitor depression , anxiety suicidal ideation 4 week well 1 week follow last rTMS administration use rating scale . These scale give week , Fridays , require roughly 40 minute complete . TMS session last approximately 25 minute .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Diagnosed MDD child adolescent psychiatrist base DSMIV , CDRS score least 60 HDRS score least 22 suffer depression current episode least 3 month Currently see Johns Hopkins psychiatrist Excellent documentation treatment resistance : least 2 different antidepressant treatment , define resistance minimum two antidepressant drug trial adequate dose duration current episode previous episode , adequacy define minimum level three ATHF per antidepressant drug trial ( complete antidepressant trial adequate dose duration due intolerance therapy may include demonstrate intolerance three antidepressant medication current previous episode ) least one course psychotherapy result significant alleviation depressive symptoms No change medication dose psychotherapy frequency previous 1 month Negative answer safety screen questionnaire rTMS History substance abuse dependence within past six month ( exclude nicotine caffeine ) mark conduct disorder oppositional behavior Any current unstable medical surgical illness Bipolar Disorder Psychotic symptom History head injury seizure history seizure first degree relative . History metal head ( outside mouth ) . Known history metallic particle eye , implanted cardiac pacemaker intracardiac line , implanted neurostimulators , surgical clip medical pump History frequent severe headache migraine History hearing loss know history cochlear implant . Pregnancy use reliable method birth control . Participation another clinical trial within 30 day study Inability locate quantify motor threshold ( MT ) define rTMS protocol Current use drug know low seizure threshold , stimulant , wellbutrin , bupropion , certain tricyclic ( e.g . clomipramine maprotiline ) Lefthanded</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>depression</keyword>
	<keyword>TMS</keyword>
	<keyword>adolescent</keyword>
	<keyword>transcranial magnetic stimulation</keyword>
	<keyword>MDD</keyword>
	<keyword>Major depression</keyword>
	<keyword>mood disorder</keyword>
</DOC>